🔎 Trials Near Me

Pradžia › Opinis kolitas › Washington › Tacoma

Opinis kolitas klinikiniai tyrimai Tacoma, WA

15 tyrimai dėl Opinis kolitas ieško dalyvių vietose Tacoma ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Renkami dalyviai3 fazė
  • Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
Visi amžiai · Visoms lytims · Atnaujinta 2026-10-02 · NCT06651281

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Renkami dalyviai2 fazė
  • Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07697456

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Renkami dalyviai2 fazė
  • Site 019, Tacoma
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-29 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Renkami dalyviai2 fazė
  • Site US-029, Tacoma
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-29 · NCT07845487

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Renkami dalyviai3 fazė
  • GI Alliance Tacoma, Tacoma
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07196748

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Renkami dalyviai2/3 fazė
  • MultiCare Health System, Tacoma
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Renkami dalyviai3 fazė
  • Washington Gastroenterology - Tacoma, Tacoma
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937086

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Renkami dalyviai2 fazė
  • Washington Gastroenterology - Tacoma, Tacoma
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Renkami dalyviai4 fazė
  • Washington Gastroenterology- GIA, Tacoma
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06095128

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Renkami dalyviai3 fazė
  • GI Alliance Tacoma, Tacoma
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT07577856

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Renkami dalyviai2 fazė
  • Digestive Health Specialists, Tacoma
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-21 · NCT06636656

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Renkami dalyviai3 fazė
  • MultiCare Institute for Research & Innovation, Tacoma
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06100289

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Renkami dalyviaiStebimasis tyrimas
  • Washington Gastroenterology, Tacoma
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-07-09 · NCT06398626

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Renkami dalyviai3 fazė
  • Multicare Health System Institute for Research and Innovation, Tacoma
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-06-22 · NCT06405087

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Renkami dalyviai2 fazė
  • Mirador Therapeutics Selected Site, Tacoma
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-03-12 · NCT07113522

Opinis kolitas tyrimai kituose miestuose

Kiti tyrimai Tacoma

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.